| Date |
Research Question / Title |
Unique ID |
Research Team |
|
June 7, 2022
|
What is the efficacy of a 4th booster dose for COVID-19?
|
EOC220304v002 RR
|
EOC
|
|
May 27, 2022
|
What is the evidence on timing and outcomes of elective surgery after a COVID infection?
|
EOC220504 RR Table
|
EOC
|
|
May 27, 2022
|
What is the evidence on timing and outcomes of elective surgery after a COVID infection?
|
EOC220504 RR
|
EOC
|
|
May 27, 2022
|
What is the efficacy of a 4th booster dose for COVID-19?
|
EOC220304v002 ESR
|
EOC
|
|
May 24, 2022
|
When should post-COVID infected patients receive booster shots?
|
EOC220503 RR Table
|
EOC
|
|
May 24, 2022
|
When should post-COVID infected patients receive booster shots?
|
EOC220503 RR
|
EOC
|
|
May 20, 2022
|
What is the evidence on timing and outcomes of elective surgery after a COVID infection?
|
EOC220504 ESR
|
EOC
|
|
May 13, 2022
|
When should post-COVID infected patients receive booster shots?
|
EOC220503 ESR
|
EOC
|
|
May 2022
|
Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR)
|
EOC220301 SBAR
|
EOC
|
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR Table
|
EOC
|
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
|
March 4, 2022
|
What is the safety/efficacy of the Novavax vaccine?
|
EOC220302 ESR
|
EOC
|
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR Table
|
EOC
|
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
|
January 25, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 ESR
|
EOC
|
|
November 5, 2021
|
What is the epidemiology of variants and what are the implications for healthcare?
|
EOC031801v017 ESR
|
EOC
|
|
August 24, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501v2 RR Table
|
EOC
|
|
August 24, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501v2 RR
|
EOC
|
|
August 17, 2021
|
What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns?
|
EOC210501v2 ESR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
